Sopharma AD (BUL:SFA)

Sopharma AD Ratios and Metrics

Market cap in millions BGN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,415	958	910	541	556	402
Market Cap Growth	44.24%	5.26%	68.20%	-2.70%	38.17%	-5.99%
Enterprise Value	2,037	1,356	1,316	841	889	801
Last Close Price	2.77	1.91	1.83	1.13	1.13	0.81
PE Ratio	13.58	12.31	9.48	7.61	6.21	13.50
Forward PE	-	11.25	11.25	11.25	11.25	11.25
PS Ratio	0.59	0.45	0.48	0.32	0.35	0.28
PB Ratio	1.53	1.13	1.21	0.76	0.84	0.71
P/TBV Ratio	2.23	1.70	1.34	0.83	0.96	0.84
P/FCF Ratio	-	22.15	44.09	5.96	-	-
P/OCF Ratio	44.51	12.51	20.21	4.92	-	-
EV/Sales Ratio	0.84	0.63	0.70	0.50	0.55	0.55
EV/EBITDA Ratio	10.37	12.01	10.29	7.07	9.47	10.80
EV/EBIT Ratio	15.11	17.77	14.10	9.80	14.45	18.48
EV/FCF Ratio	-378.26	31.35	63.74	9.27	-	-
Debt / Equity Ratio	0.67	0.56	0.47	0.40	0.50	0.75
Debt / EBITDA Ratio	3.94	3.59	2.41	2.10	2.95	4.84
Debt / FCF Ratio	-	11.10	17.00	3.12	-	-
Asset Turnover	1.40	1.29	1.37	1.36	1.32	1.20
Inventory Turnover	4.49	4.24	4.76	4.89	4.65	4.37
Quick Ratio	0.68	0.52	0.70	0.66	0.70	0.56
Current Ratio	1.30	1.17	1.29	1.41	1.35	1.12
Return on Equity (ROE)	12.55%	10.28%	13.59%	11.10%	14.97%	4.43%
Return on Assets (ROA)	3.50%	2.88%	4.21%	4.37%	3.14%	2.24%
Return on Capital (ROIC)	4.43%	3.92%	5.54%	5.39%	3.88%	2.73%
Return on Capital Employed (ROCE)	8.10%	7.10%	10.30%	10.10%	7.90%	6.20%
Earnings Yield	7.24%	8.13%	10.55%	13.14%	16.09%	7.41%
FCF Yield	-0.38%	4.52%	2.27%	16.77%	-17.32%	-50.43%
Dividend Yield	1.91%	2.71%	18.00%	17.76%	-	-
Payout Ratio	27.13%	216.37%	74.90%	0.01%	0.07%	75.97%
Buyback Yield / Dilution	-5.20%	-19.22%	-10.64%	0.36%	0.31%	0.11%
Total Shareholder Return	-3.29%	-16.50%	7.36%	18.13%	0.31%	0.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.